GROUP INTRODUCTION
Bocheng Medical Investment Group (hereinafter referred to as "Bocheng Medical") was established in 2016. It is a medical investment and post-investment operation company jointly composed of authoritative experts and professional teams in assisted reproduction and obstetrics and gynecology at home and abroad.
Since its establishment, Bocheng Medical has actively distributed assisted reproductive institutions at home and abroad, and built a multi-level medical and service system. At present, its institutions are mainly distributed in China and North America, and established extensive cooperation with famous assisted reproductive institutions in Southeast Asia, Russia, Georgia, Mexico and other countries
MORE >4 Availability
Mainly distributed in China and North America
30 +Years
Experienced American expert team
30000Case
IVF cycle cases
75%~80%
Fetal live birth rate
GROUP BUSINESS
GLOBAL LAYOUT
Envita Fertility CenterGen 5 Fertility Center
Shanghai- Headquaters of Bocheng Bocheng- Bocheng Medical
Mexico
Georgia
Greece
Russia
Thailand
NEWS
- Company news
- Industry information
- Activity meeting
- Special report
ART and Intracytoplasmic Sperm Injection (ICSI) in the United States
Intracytoplasmic sperm injection (ICSI) is a technique used during in vitro fertilization (IVF) where a single sperm is injected directly into the egg for the purpose of fertilization.
11-16What can be done to increase the success rate of IVF?
In order to increase IVF success rates, a thorough gynaecological evaluation is important before commencing on an IVF cycle. Laparoscopic or minimally invasive key-hole surgery may sometimes be recom
11-16Envita fertility center laboratories
Success is in the laboratories. See what new technology we're using in ours to help increase success rates.
11-05GLOBAL HOSPITAL